---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-101343"
form_type: "8-K/A"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2022-09-20T23:59:59+00:00"
generated_at: "2026-06-23T08:31:19.491045+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Biostage adopts annual say-on-pay votes after stockholder advisory vote

## Summary
- Advisory vote: 7,539,731 shares favored one year, 28,038 three years, 110,760 abstained.
- Board decided to hold future say-on-pay votes annually until next frequency vote (no later than 2028).
- Amendment solely discloses frequency decision; no other changes to original 8-K from June 22, 2022.

## SEC filing metadata
- accession: 0001104659-22-101343
- form_type: 8-K/A
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2022-09-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000110465922101343/0001104659-22-101343-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000110465922101343/tm2226229d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-101343
- JSON: https://secwatch.observer/filing/0001104659-22-101343.json
- Plain text: https://secwatch.observer/filing/0001104659-22-101343.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.